Raab & Moskowitz Asset Management LLC
Source: SEC Form 13F · as of Mar 2026Raab & Moskowitz Asset Management LLC holds 16 biotech & pharma companies tracked by BioSniper, totaling $36.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$36.1M
| Company | Shares | Value |
|---|---|---|
| PFEPFIZER INC | 232,244 | $6.5M |
| MRKMerck & Co., Inc. | 52,718 | $6.3M |
| JNJJOHNSON & JOHNSON | 23,202 | $5.7M |
| ABBVAbbVie Inc. | 25,782 | $5.6M |
| PMPhilip Morris International Inc | 16,464 | $2.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,949 | $1.9M |
| LLYELI LILLY & Co | 1,850 | $1.7M |
| ABTABBOTT LABORATORIES | 15,536 | $1.6M |
| BMYBRISTOL MYERS SQUIBB CO | 16,565 | $1.0M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,701 | $760K |
| GILDGILEAD SCIENCES, INC. | 4,144 | $578K |
| DGXQuest Diagnostics Incorporated | 2,371 | $465K |
| SNYSanofi | 9,307 | $448K |
| ROIVRoivant Sciences Ltd. | 11,000 | $305K |
| AMGNAMGEN INC | 757 | $266K |
| IONSIONIS PHARMACEUTICALS INC | 3,115 | $234K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.